← Open Payments lookup

MICHAEL MILLER: Open Payments

NPI 1881039931 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,026 in 96 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $2,026

Food & beverage: $2,026
CompanyPaymentsAmount
Axsome Therapeutics, Inc.14$431
ABBVIE INC.15$270
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)15$190
Neurocrine BioSciences, Inc.5$141
Janssen Pharmaceuticals, Inc5$132
Lundbeck LLC6$130
Tris Pharma Inc5$112
E.R. Squibb & Sons, L.L.C.5$111
Otsuka America Pharmaceutical, Inc.5$101
Teva Pharmaceuticals USA, Inc.5$99

Products named: Auvelity, VRAYLAR, CAPLYTA, INGREZZA, REXULTI, SPRAVATO, COBENFY, TRINTELLIX.

Industry payments across TX — which companies pay providers there.